Literature DB >> 9786507

P2X receptor-mediated excitation of nociceptive afferents in the normal and arthritic rat knee joint.

E Dowd1, D S McQueen, I P Chessell, P P Humphrey.   

Abstract

1. We tested the hypothesis that functional P2X receptors are present on peripheral terminals of primary afferent articular nociceptors in the rat knee joint. Neural activity was recorded extracellularly from the medial articular nerve innervating the knee joint in rats anaesthetized with pentobarbitone. 2. The selective P2X receptor agonist, alphabeta methylene ATP (alphabetameATP), and the endogenous ligand, ATP, caused a rapid short-lasting excitation of a sub-population of C and Adelta nociceptive afferent nerves innervating normal knee joints when injected intra-arterially or intra-articularly, and this effect was antagonized by the non-selective P2 receptor antagonist PPADS. 3. Induction of a chronic (14-21 days) unilateral inflammatory arthritis of the knee joint using locally injected Freund's adjuvant neither increased or decreased responsiveness of joint nociceptors to alphabetameATP or ATP. 4. Our results support the hypothesis that alphabetameATP-sensitive P2X receptors are expressed on peripheral nociceptive afferents in the rat knee joint suggesting that they may be involved in the initiation of nociception and pain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9786507      PMCID: PMC1565628          DOI: 10.1038/sj.bjp.0702080

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

1.  Excitatory effect of P2X receptor activation on mesenteric afferent nerves in the anaesthetised rat.

Authors:  A J Kirkup; C E Booth; I P Chessell; P P Humphrey; D Grundy
Journal:  J Physiol       Date:  1999-10-15       Impact factor: 5.182

2.  In vivo pathway of thermal hyperalgesia by intrathecal administration of alpha,beta-methylene ATP in mouse spinal cord: involvement of the glutamate-NMDA receptor system.

Authors:  M Tsuda; S Ueno; K Inoue
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

Review 3.  Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction.

Authors:  G Burnstock
Journal:  J Anat       Date:  1999-04       Impact factor: 2.610

4.  Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue.

Authors:  M F Jarvis; C T Wismer; E Schweitzer; H Yu; K J Lynch; E C Burgard; E A Kowaluk
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 5.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 6.  P2X3 receptor involvement in pain states.

Authors:  Kerstin Wirkner; Beata Sperlagh; Peter Illes
Journal:  Mol Neurobiol       Date:  2007-07-17       Impact factor: 5.590

Review 7.  Crossing the pain barrier: P2 receptors as targets for novel analgesics.

Authors:  C Kennedy; T S Assis; A J Currie; E G Rowan
Journal:  J Physiol       Date:  2003-09-26       Impact factor: 5.182

Review 8.  P2X3 receptors and peripheral pain mechanisms.

Authors:  R Alan North
Journal:  J Physiol       Date:  2003-06-27       Impact factor: 5.182

9.  Cartilage degeneration is associated with augmented chemically-induced joint pain in rats: a pilot study.

Authors:  Meguru Okamoto; Yuji Atsuta
Journal:  Clin Orthop Relat Res       Date:  2009-12-15       Impact factor: 4.176

10.  Functional downregulation of P2X3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain.

Authors:  Jane Barclay; Sadhana Patel; Gabriele Dorn; Glen Wotherspoon; Sarah Moffatt; Louise Eunson; Samir Abdel'al; Francois Natt; Jonathan Hall; Janet Winter; Stuart Bevan; William Wishart; Alyson Fox; Pam Ganju
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.